Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)
10,910
-310 (-2.76%)
At close: Jun 5, 2025, 3:30 PM KST
KRX:019170 Revenue
Shinpoong Pharmaceutical Co.,Ltd had revenue of 55.41B KRW in the quarter ending March 31, 2025, with 2.60% growth. This brings the company's revenue in the last twelve months to 222.50B, up 8.08% year-over-year. In the year 2024, Shinpoong Pharmaceutical Co.,Ltd had annual revenue of 221.09B with 10.42% growth.
Revenue (ttm)
222.50B
Revenue Growth
+8.08%
P/S Ratio
2.71
Revenue / Employee
271.67M
Employees
819
Market Cap
603.46B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 221.09B | 20.87B | 10.42% |
Dec 31, 2023 | 200.23B | -9.06B | -4.33% |
Dec 31, 2022 | 209.29B | 20.05B | 10.60% |
Dec 31, 2021 | 189.24B | -8.51B | -4.31% |
Dec 31, 2020 | 197.75B | 8.03B | 4.23% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
LigaChem Biosciences | 146.42B |